SG89287G - Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals - Google Patents

Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals

Info

Publication number
SG89287G
SG89287G SG892/87A SG89287A SG89287G SG 89287 G SG89287 G SG 89287G SG 892/87 A SG892/87 A SG 892/87A SG 89287 A SG89287 A SG 89287A SG 89287 G SG89287 G SG 89287G
Authority
SG
Singapore
Prior art keywords
pharmaceuticals
processes
production
pharmaceutical compositions
compositions containing
Prior art date
Application number
SG892/87A
Other languages
English (en)
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4328536&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG89287(G) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of SG89287G publication Critical patent/SG89287G/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/04—Acyclic alcohols with carbon-to-carbon triple bonds
    • C07C33/048—Acyclic alcohols with carbon-to-carbon triple bonds with double and triple bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/05—Alcohols containing rings other than six-membered aromatic rings
    • C07C33/12—Alcohols containing rings other than six-membered aromatic rings containing five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/12—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/08—Hydrogen atoms or radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/58—Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicinal Preparation (AREA)
  • Radiation-Therapy Devices (AREA)
  • Replacement Of Web Rolls (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SG892/87A 1979-08-22 1987-10-13 Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals SG89287G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH765679 1979-08-22

Publications (1)

Publication Number Publication Date
SG89287G true SG89287G (en) 1988-09-30

Family

ID=4328536

Family Applications (1)

Application Number Title Priority Date Filing Date
SG892/87A SG89287G (en) 1979-08-22 1987-10-13 Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals

Country Status (24)

Country Link
US (1) US4755534A (ko)
EP (1) EP0024587B1 (ko)
JP (2) JPS5632440A (ko)
AT (1) ATE10272T1 (ko)
AU (1) AU538928B2 (ko)
CA (1) CA1157023A (ko)
CY (1) CY1410A (ko)
DE (3) DE3069633D1 (ko)
DK (1) DK153470C (ko)
ES (1) ES8105694A1 (ko)
FI (1) FI65775C (ko)
HK (1) HK21588A (ko)
IE (1) IE50878B1 (ko)
IL (1) IL60877A (ko)
KE (1) KE3775A (ko)
LU (1) LU88343I2 (ko)
MY (1) MY8600181A (ko)
NL (1) NL930136I2 (ko)
NZ (1) NZ194714A (ko)
PH (1) PH22166A (ko)
PT (1) PT71717B (ko)
SG (1) SG89287G (ko)
YU (1) YU41513B (ko)
ZA (1) ZA805185B (ko)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5132459A (en) * 1979-08-22 1992-07-21 Sandoz Ltd. Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
CH653028A5 (de) * 1982-02-03 1985-12-13 Sandoz Ag Benzthiophenallylamin-verbindungen und verfahren zu ihrer herstellung.
FR2526423B1 (fr) * 1982-05-07 1987-07-10 Sandoz Sa Nouvelles amines insaturees, leur preparation et leur utilisation comme medicaments
JPS6145A (ja) * 1984-06-09 1986-01-06 Kaken Pharmaceut Co Ltd Ｎ‐（４‐ｔｅｒｔ‐ブチルベンジル）‐Ｎ‐メチル‐１‐ナフチルメチルアミンおよびそれを有効成分とする抗真菌剤
DE3582060D1 (de) * 1984-11-22 1991-04-11 Sandoz Ag Homopropargylamine.
CH672311A5 (ko) * 1985-09-14 1989-11-15 Sandoz Ag
NL8700083A (nl) * 1986-01-29 1987-08-17 Sandoz Ag Tegen schimmels werkende aminen, werkwijzen voor de bereiding daarvan en hun toepassing.
US4751245A (en) * 1986-06-25 1988-06-14 E. R. Squibb & Sons, Inc. Antifungal derivatives of N-(6,6-dimethyl-2-hepten-4-ynyl)-1-naphthalenemethanamine and method of using same
EP0254677A1 (en) * 1986-07-08 1988-01-27 Sandoz Ag Antimycotic 6-phenyl-2-hexen-4-ynamines
JPS63238060A (ja) * 1987-03-26 1988-10-04 Maruho Kk キノリン誘導体
CA1327795C (en) * 1987-08-14 1994-03-15 Jules Freedman Antidepressants which are aryloxy inadanamines
US5149714A (en) * 1987-08-14 1992-09-22 Merrell Dow Pharmaceuticals Inc. Antidepressants
NZ227042A (en) 1987-11-27 1991-05-28 Banyu Pharma Co Ltd Substituted alkylamine derivatives and pharmaceutical compositions
US5234946A (en) * 1987-11-27 1993-08-10 Banyu Pharmaceutical Co., Ltd. Substituted alkylamine derivatives
EP0363326A3 (en) * 1988-10-07 1991-10-09 Sandoz Ag Fungicidal amines
EP0378457B1 (en) * 1989-01-12 1994-08-03 Sumitomo Chemical Company Limited Aromatic allyl amine thermosetting resin composition
JP3116364B2 (ja) * 1989-10-02 2000-12-11 萬有製薬株式会社 エンイン誘導体の製造法
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
GB9111611D0 (en) 1991-05-30 1991-07-24 Sandoz Ltd Liposomes
JPH04138020U (ja) * 1991-06-14 1992-12-24 日立機材株式会社 バケツトエレベータ
GB9513750D0 (en) * 1995-07-06 1995-09-06 Sandoz Ltd Use of allylamines
NZ280065A (en) * 1995-09-20 1998-04-27 Apotex Inc Preparation of n-alkyl-n-(1-naphthylmethyl)alk-2-en-4-ynylamine derivatives
US6075056A (en) * 1997-10-03 2000-06-13 Penederm, Inc. Antifungal/steroid topical compositions
SK5202000A3 (en) 2000-04-07 2001-12-03 Slovakofarma As Method for the preparation of (e)-n-(6,6-dimethyl-2-hepten-4- inyl)-n-methyl-1-naphthalenemethylamine (terbinaphin)
US7199246B2 (en) * 2000-06-09 2007-04-03 Merial Limited Process for the preparation of pesticidal compounds
IL137364A (en) * 2000-07-18 2005-08-31 Chemagis Ltd Process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol
GB0103046D0 (en) 2001-02-07 2001-03-21 Novartis Ag Organic Compounds
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
KR100459275B1 (ko) 2001-12-28 2004-12-03 주식회사유한양행 터비나핀 또는 그의 염산염의 제조방법
BG65097B1 (bg) * 2002-03-15 2007-02-28 Richter Gedeon Vegyeszeti Gyar Rt. Метод за получаване на заместено производно на алиламин и на съответните му соли
WO2007014130A2 (en) * 2005-07-21 2007-02-01 Nomir Medical Technologies, Inc. Near infrared microbial elimination laser system (nimels)
US8404751B2 (en) 2002-09-27 2013-03-26 Hallux, Inc. Subunguicide, and method for treating onychomycosis
KR101093990B1 (ko) 2003-03-21 2011-12-16 넥스메드 홀딩스 인코포레이티드 항진균성 네일 코트 및 사용 방법
US20050197512A1 (en) * 2003-08-29 2005-09-08 Ulrich Beutler Purification process
GB0503942D0 (en) * 2005-02-25 2005-04-06 Novartis Ag Purification process
GB0320312D0 (en) * 2003-08-29 2003-10-01 Novartis Ag Purification process
US7112561B2 (en) 2003-12-08 2006-09-26 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for insulin treatment
ES2245596B1 (es) * 2004-06-10 2007-07-01 Ercros Industrial, S.A. Procedimiento para la obtencion de clorhidrato de terbinafina.
US20060004230A1 (en) * 2004-06-30 2006-01-05 Joseph Kaspi Process for the preparation of terbinafine and salts thereof
BRPI0512841A (pt) * 2004-07-02 2008-01-08 Warner Lambert Co composições e métodos para o tratamento de infecções patológicas
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
CN1293037C (zh) * 2004-11-03 2007-01-03 浙江海正药业股份有限公司 一种制备特比萘芬盐酸盐的方法
WO2008073863A2 (en) * 2006-12-08 2008-06-19 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted allylamines
US20080176908A1 (en) * 2007-01-18 2008-07-24 Mcanally Weylan R Method of using squalene monooxygenase inhibitors to treat acne
US20090082469A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched terbinafine
EP2317993A2 (en) * 2008-07-23 2011-05-11 Tdt, Ltd Methods of administering topical antifungal formulations for the treatment of fungal infections
EP2730271B1 (en) 2012-11-11 2018-01-24 Symrise AG Aqeuous compositions
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
ES2701758T3 (es) 2013-02-27 2019-02-25 Symrise Ag Extracto de jengibre para la protección de citoblastos
US9498612B2 (en) 2013-03-14 2016-11-22 Hallux, Inc. Method of treating infections, diseases or disorders of nail unit
EP2862852B1 (en) 2013-10-18 2018-07-04 Symrise AG Urea derivatives for the protection of stem cells
EP2921157B1 (en) 2014-03-18 2017-08-16 Symrise AG Coated titanium dioxide to reduce whitening effect on skin
EP2939710B1 (en) 2014-04-29 2020-06-17 Symrise AG Active Mixtures
EP3045161A1 (en) 2015-01-18 2016-07-20 Symrise AG Active compositions comprising 1,2-hexanediol and 1,2-octanediol
CN104725240B (zh) * 2015-02-12 2017-05-24 吉林修正药业新药开发有限公司 一种盐酸特比萘芬z型异构体的制备方法
CN108084125B (zh) * 2016-11-23 2020-08-18 华东理工大学 苯并杂环烷基胺类化合物及其用途
CN114727689B (zh) 2019-11-12 2023-11-03 Ykk株式会社 拉链

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE623609A (ko) * 1961-10-27
DE2716943C2 (de) * 1976-04-28 1986-08-14 Sandoz-Patent-GmbH, 7850 Lörrach N-(3-Phenyl-2-propenyl)-N-(1-naphthylmethyl)-amine, ihre Verwendung und Herstellung
EP0000896B1 (en) * 1977-08-19 1982-10-13 Sandoz Ag Propenyl amines, processes for their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DK153470C (da) 1988-11-28
US4755534A (en) 1988-07-05
DK153470B (da) 1988-07-18
YU41513B (en) 1987-08-31
PH22166A (en) 1988-06-28
MY8600181A (en) 1986-12-31
JPH0415216B2 (ko) 1992-03-17
ATE10272T1 (de) 1984-11-15
YU209680A (en) 1983-10-31
DE19375084I2 (de) 2000-11-16
DK357980A (da) 1981-02-23
AU538928B2 (en) 1984-09-06
IE50878B1 (en) 1986-08-06
JPS6342612B2 (ko) 1988-08-24
CA1157023A (en) 1983-11-15
ES494408A0 (es) 1981-06-16
ZA805185B (en) 1982-03-31
FI802583A (fi) 1981-02-23
FI65775C (fi) 1984-07-10
JPS63313753A (ja) 1988-12-21
IE801770L (en) 1981-02-22
HK21588A (en) 1988-03-31
NL930136I1 (nl) 1993-11-01
PT71717B (en) 1981-09-24
NL930136I2 (nl) 1998-10-01
DE19975055I1 (de) 2000-01-27
NZ194714A (en) 1984-11-09
LU88343I2 (fr) 1994-05-04
FI65775B (fi) 1984-03-30
PT71717A (en) 1980-09-01
KE3775A (en) 1987-11-27
JPS5632440A (en) 1981-04-01
EP0024587A1 (en) 1981-03-11
ES8105694A1 (es) 1981-06-16
IL60877A0 (en) 1980-10-26
IL60877A (en) 1984-08-31
EP0024587B1 (en) 1984-11-14
AU6159280A (en) 1981-04-16
CY1410A (en) 1988-04-22
DE3069633D1 (en) 1984-12-20

Similar Documents

Publication Publication Date Title
DE3069633D1 (en) Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
ES441673A1 (es) Un procedimiento para la preparacion de sales de biguanida.
DE3069408D1 (en) 5-oxo- and 5-thioxoproline derivatives, process for their production and pharmaceutical compositions containing them
ATE104273T1 (de) Benzolsulfonamide und verfahren zu ihrer herstellung.
ES461980A1 (es) Un procedimiento para la preparacion de nuevos derivados delimidazol.
DE3267188D1 (en) Hydroxybenzylamino-aryl compounds, process for preparing and pharmaceutical compositions containing the same
ES483247A1 (es) Procedimiento para la obtencion de nuevos diazacicloalquenostiosustituidos
ATE21693T1 (de) Substituierte pyrimid-2-one, ihre salze, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die diese enthalten.
ES481271A1 (es) Procedimiento de preparacion de derivados de la l-cisteina.
ES8201575A1 (es) Procedimiento de obtencion de nuevos 2-aminoetanoles
ES450211A1 (es) Procedimiento para la obtencion de nuevos derivados de la 1-hidroxi-benzo-2,3,1-diazaborina.
DE3260242D1 (en) 4-phenoxy-3-hydroxy-butyramidoxime derivatives, preparation thereof and use thereof as medicaments
GB975924A (en) N-heterocyclic 2,6-dialkylbenzoic acid esters